Figure 2.
Prevalence of estimated CVD risk according to Framingham, Framingham with aggravating factors (Brazilian Guideline for Dyslipidemia and Atherosclerosis Prevention), PROCAM and DAD risk equations for 283 HIV-infected patients.
Prevalence of estimated CVD risk according to Framingham, Framingham with aggravating factors (Brazilian Guideline for Dyslipidemia and Atherosclerosis Prevention), PROCAM and DAD risk equations for 283 HIV-infected patients.